Literature DB >> 23899915

Predictors of stroke in patients with impaired glucose tolerance: results from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.

David Preiss1, Thomas D Giles, Laine E Thomas, Jie-Lena Sun, Steven M Haffner, Rury R Holman, Eberhard Standl, Theodore Mazzone, Guy E Rutten, Gianni Tognoni, Fu-Tien Chiang, John J V McMurray, Robert M Califf.   

Abstract

BACKGROUND AND
PURPOSE: Risk factors for stroke are well-established in general populations but sparsely studied in individuals with impaired glucose tolerance.
METHODS: We identified predictors of stroke among participants with impaired glucose tolerance in the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial. Cox proportional-hazard regression models were constructed using baseline variables, including the 2 medications studied, valsartan and nateglinide.
RESULTS: Among 9306 participants, 237 experienced a stroke over 6.4 years. Predictors of stroke included classical risk factors such as existing cerebrovascular and coronary heart disease, higher pulse pressure, higher low-density lipoprotein cholesterol, older age, and atrial fibrillation. Other factors, including previous venous thromboembolism, higher waist circumference, lower estimated glomerular filtration rate, lower heart rate, and lower body mass index, provided additional important predictive information, yielding a C-index of 0.72. Glycemic measures were not predictive of stroke. Variables associated with stroke were similar in participants with no prior history of cerebrovascular disease at baseline.
CONCLUSIONS: The most powerful predictors of stroke in patients with impaired glucose tolerance included a combination of established risk factors and novel variables, such as previous venous thromboembolism and elevated waist circumference, allowing moderately effective identification of high-risk individuals.

Entities:  

Keywords:  impaired glucose tolerance; stroke

Mesh:

Substances:

Year:  2013        PMID: 23899915     DOI: 10.1161/STROKEAHA.113.001177

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  2 in total

1.  The interactive effect of diabetes and central obesity on stroke: a prospective cohort study of inner Mongolians.

Authors:  Jennifer Olofindayo; Hao Peng; Yan Liu; Hongmei Li; Mingzhi Zhang; Aili Wang; Yonghong Zhang
Journal:  BMC Neurol       Date:  2015-04-28       Impact factor: 2.474

Review 2.  On the potential of acarbose to reduce cardiovascular disease.

Authors:  Eberhard Standl; Michael J Theodorakis; Michael Erbach; Oliver Schnell; Jaakko Tuomilehto
Journal:  Cardiovasc Diabetol       Date:  2014-04-16       Impact factor: 9.951

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.